Stock Earnings

Question 1

Rigel Pharmaceuticals Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Rigel Pharmaceuticals Inc의 총 자산은 $163이며, 순profit입니다.

Question 2

RIGL의 주요 재무 비율은 무엇인가요?

Accepted Answer

Rigel Pharmaceuticals Inc의 유동비율은 1.01이고, 순이익률은 9.49, 주당 매출은 $10.12입니다.

Question 3

Rigel Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Rigel Pharmaceuticals Inc largest revenue segment is Novel Therapies, at a revenue of 116,882,000 in the most earnings release.For geography, United States is the primary market for Rigel Pharmaceuticals Inc, at a revenue of 116,882,000.

Question 4

Rigel Pharmaceuticals Inc은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Rigel Pharmaceuticals Inc의 순profit은 $17입니다.

Question 5

Rigel Pharmaceuticals Inc에 부채가 있나요?

Accepted Answer

yes, Rigel Pharmaceuticals Inc의 부채는 160입니다.

Question 6

Rigel Pharmaceuticals Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Rigel Pharmaceuticals Inc의 총 발행 주식은 17.71주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	267	179	116	120	149	108
Revenue Growth (YoY)	105%	54%	-3%	-19%	38%	83%
Cost of Revenue	22	18	7	1	1	0
Gross Profit	245	160	109	118	148	107
Selling, General & Admin	113	113	105	112	91	76
Research & Development	27	23	24	60	65	60
Operating Expenses	140	136	130	172	157	136
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	99	18	-25	-58	-17	-29
Income Tax Expense	1	0	--	0	0	--
Net Income	97	17	-25	-58	-17	-29
Net Income Growth	-793%	-168%	-56.99%	241%	-41%	-56%
Shares Outstanding (Diluted)	18.16	17.68	17.4	172.4	170.5	168.8
Shares Change (YoY)	3%	2%	-90%	1%	1%	1%
EPS (Diluted)	5.38	0.98	-1.44	-0.34	-0.11	-0.18
EPS Growth	-764%	-169%	324%	209%	-39%	-55%
Free Cash Flow	65	31	-20	-74	5	-53
Free Cash Flow Per Share	3.57	1.75	-1.14	-0.42	0.02	-0.31
Gross Margin	91.76%	89.38%	93.96%	98.33%	99.32%	99.07%
Operating Margin	38.95%	13.4%	-17.24%	-45%	-6.04%	-26.85%
Profit Margin	36.32%	9.49%	-21.55%	-48.33%	-11.4%	-26.85%
Free Cash Flow Margin	24.34%	17.31%	-17.24%	-61.66%	3.35%	-49.07%
EBITDA	106	26	-19	-53	-8	-29
EBITDA Margin	39.7%	14.52%	-16.37%	-44.16%	-5.36%	-26.85%
D&A For EBITDA	2	2	1	1	1	0
EBIT	104	24	-20	-54	-9	-29
EBIT Margin	38.95%	13.4%	-17.24%	-45%	-6.04%	-26.85%
Effective Tax Rate	1.01%	0%	--	0%	0%	--

Rigel Pharmaceuticals Inc (RIGL) Price

RIGL Stock Price Chart

RIGL Income

Follow-Up Questions